Compare Abeona Therapeutics Inc (ABEO) vs Plug Power Inc (PLUG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Plug Power Inc — how do they compare? Abeona Therapeutics Inc trades at $6.62 (market cap $373.32M), while Plug Power Inc trades at $2.5 (market cap $3.46B). The key difference: Plug Power Inc is far larger — about 9.3× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | PLUG | |
|---|---|---|
Market Cap | $373.32M | $3.46B |
Sector | Health | Industrials |
52-Week High | $7.23 | $4.14 |
52-Week Low | $4.17 | $1.40 |
Enterprise Value | $228.22M | $4.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Plug Power (PLUG) trades at $2.48, down 6.06% today amid sector-wide profit-taking, despite recent operational milestones. The stock shows a bearish technical signal with key resistance at $3.00. Fundamentally, the company reported a net loss of $1.63 billion in 2025 with negative gross and net margins, though it has beaten EPS estimates for three consecutive quarters. Revenue grew to $709.92 million in 2025 from $629 million in 2024, but cash flow remains negative, requiring financing to cover operations.
The outlook is high-risk with a path to profitability projected by 2028, but consistent losses and high cash burn pose significant challenges. Analyst consensus is mixed with a $3.28 price target, offering potential upside, yet investors face substantial execution and funding risks. The stock's viability hinges on successful scaling of hydrogen projects and achieving positive cash flow.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
